Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Fatigue in Chronic Illness
NCT04141696Phase 2Completed
- Sponsor
- National Institute of Nursing Research
- Start
- Jul 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in fatigue (2 arms), sponsored by National Institute of Nursing Research. Primary endpoint: Percentage Change in Self-reported Fatigue Visual Analog Scale at 3 days. Started Jul 2021; status: completed.
02
Drugs
ketamine
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT04141696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141696.